Purpose. Chemokines are important in the immune response against viral infections, and may play a role in human Tlymphotropic virus 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) pathogenesis. Polymorphisms in the Duffy antigen receptor for chemokines (DARC), such as rs12075 (A>G; FY*B>FY*A) and rs281477 (À46T>C; GATA-1 box) may influence circulating concentrations of proinflammatory chemokines. We investigate whether Duffy genotypes influence the HTLV-1 proviral load (PVL) level, HTLV-1 infection outcome and chemokine concentrations in HTLV-1 asymptomatic carriers (AC=162), HAM/TSP patients (HAM=135) and seronegative individuals (SN=71).
INTRODUCTION
Human T-lymphotropic virus 1 (HTLV-1) infects 15-20 million individuals worldwide and may cause, in 5-10 % of infected persons, a malignant disease, known as adult Tcell leukemia (ATL) and inflammatory conditions, including HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) [1] . The pathogenesis of HAM/TSP involves the migration of infected cells and HTLV-1-specific CD8+ cells from blood to the central nervous system (CNS), leading to a chronic inflammatory response that impairs nervous cells [2, 3] . Several studies have shown that high levels of HTLV-1 proviral load (PVL) in blood and in the CNS is a risk marker for HAM/TSP development [4] [5] [6] [7] .
Chemokines are small molecules that play a role in the migration of immune cells from blood to specific tissues.
They regulate the cell traffic of various types of leukocytes through interactions with a subset of 7-transmembrane, G protein-coupled receptors on the surface of circulating and endothelial cells [8] . Since HAM/TSP is characterized by an inflammatory condition in the CNS, the level of chemokines in blood and the cerebrospinal fluid may be a risk factor to HAM/TSP outcome [9, 10] .
The Duffy antigen receptor for chemokines (DARC) is a high affinity receptor for pro-inflammatory chemokines, such as CCL2 (MCP-1, monocyte chemoattractant protein-1), CCL5 (RANTES, regulated on activation, normal T-cell expressed and secreted) and IL8 (Interleukin 8, CXCL8), but do not bind CCL3 (MIP-1a, macrophage inflammatory protein) and CCL4 (MIP-1b) [11] . However, the chemokine ligation on DARC does not transmit a signal via G proteins. DARC is a glycoprotein present on red blood cells (RBCs) and is expressed by erythroid and non-erythroid cells, such as neurons, endothelial cells from brain, kidney and spleen, and lung epithelial cells [12] . The two major codominant alleles in the Duffy blood group are FY*A and FY*B, which differ by a single nucleotide polymorphism (SNP) 125G>A with an amino acid substitution Gly42Asp and codify for Fy a and Fy b antigens, respectively, originating four phenotypes: Fy (a+b+), Fy(a+bÀ), Fy(aÀb+) and Fy(aÀbÀ) [13] . Since DARC is also a receptor for Plasmodium vivax, individuals with the null phenotype present more resistance against malaria, which leads to it being present in >95 % of the West African population and in about 68 % of Afro-Americans, whereas it is rare in Caucasians [12, 14, 15] . The null phenotype is associated with a recessive FY*B ES allele, that shows an SNP in the GATA-1 box on the promotor region of the Duffy gene (À46T>C), which disrupts the erythrocyte-specific transcription binding site, abrogating the DARC expression only on RBCs [16, 17] .
Considering that chemokines bound to erythrocyte DARC are not accessible to leukocytes, some studies have proposed that DARC functions as a 'sink' for circulating chemokines, binding intravascular chemokines that become unable to activate leukocytes [18, 19] . Thus, it is hypothesized that expression of DARC on the surface of RBCs may regulate inflammatory responses leading to circulating chemokine levels being changed in blood and tissues. In addition, the absence of DARC on RBCs is associated with lower leukocytes and neutrophil levels [20, 21] . As a result, functional polymorphisms in DARC may contribute to individual variability in inflammatory responses.
We investigated whether polymorphisms rs12075 (A>G; FY*B>FY*A) and rs281477 (À46T>C; FY*B>FY*B ES ), that change DARC expression on RBCs, influence the plasmatic level of IL8, CCL2 and CCL5 and whether they are associated with the HTLV-1 PVL level and HAM/TSP. To the best of our knowledge, this is the first study to analyse the influence of Duffy genotypes on HTLV-1 infection outcome.
METHODS

Population study
We analysed 162 HTLV-1 asymptomatic carriers (AC), 135 HAM/TSP patients (HAM) and 71 healthy HTLV seronegative individuals (SN) as the control group. AC and SN subjects were blood donors enrolled in the GIPH (Interdisciplinary HTLV Research Group) cohort study, which began in 1997 at a public blood centre (Fundação Hemominas, Belo Horizonte, Brazil). HAM were from a rehabilitation hospital (Rede Sarah, Belo Horizonte, Brazil). AC and HAM groups were classified according to the World Health Organization's (WHO) criteria [22] and HTLV-1 infection was diagnosed by ELISA or chemiluminescence tests and was confirmed by Western blot (WB HTLV 2.4, Genelabs Diagnostics, Singapore) or real-time PCR [23] . All subjects were seronegative for other blood-borne pathogens tested at Fundação Hemominas (HIV, HCV, HBV, Chagas disease and syphilis) whose screening tests are mandatory in donated blood in Brazil. Total WBC count and neutrophils were obtained from an automatic blood count test (Beckman Coulter T890, CA, USA) close to when the sample used for PVL and chemokine analysis was collected.
Duffy genotyping by real-time PCR Duffy genotyping was performed for all participants by realtime PCR, using genomic DNA from peripheral blood. Two distinct tests were standardized for the detection of FY*B and FY*A alleles, and the wild and mutated GATA-1 box (FY*B and FY*B ES alleles, respectively) in a 20 µl reaction using the primers described previously [24] and probes designed using the Primer Express Software (Applied Biosystems, Foster City, CA, USA). The primers and probes used for genotyping the FY*A and FY*B alleles were as follows: FY1 (5¢-CTGAGAAC TCAAGTCAGCTG-3¢); FY2 (5¢-AGGATGAAGAAGGG-CAGTGC-3¢); FYA-P (5¢-VIC-CAGATGGAGACTATGG TG-3¢); FYB-P (5¢-FAM-ATGGAGACTATGATGCCA-3¢). The primers and probes used for genotyping the GATA region were as follows: GATA-1 (5¢-CGTGGGGTAAGGCTTCC TGA-3¢); GATA-2 (5¢-CTGTGCAGACAGTTCCCCAT-3¢); GATA-W (5¢-VIC-TTGGCTCTTATCTTGGA-3¢); GATA-M (5¢-FAM-TTGGCTCTTACCTTGG-3¢). The tests used 1X PCR Genotyping Master Mix Kit (Applied Biosystems, Foster City, CA, USA), 100 ng of DNA, 600 nM of primers and 200 nM of each of the fluorescent MGB probes specific for each Duffy polymorphism. Both reactions were performed on a real-time PCR system model ABI 7500 Fast (Applied Biosystems, Foster City, CA, USA) under the following conditions: a pre-amplification step of 60 C for 30 min and 95 C for 10 min, followed by 50 cycles at 92 C for 15 s and 60 C for 1.5 min, and a post-amplification step of 60 C for 30 s. The analysis was performed using the allelic discrimination plot.
Quantification of HTLV-1 PVL DNA isolated from peripheral blood by column extraction kit (QIAamp DNA Blood kit; Qiagen GmbH, Hilden, Germany) was used to quantify HTLV-1 PVL by a real-time SYBR Green PCR method, as previously described [7] . A 186 bp fragment of the pol gene was amplified with primers SK110 (5¢-CCCTACAATCCAACCAGCTCAG-3¢) and SK111 (5¢-GTGGTGAAGCTGCCATCGGGTTTT-3¢), in parallel with the amplification of the albumin gene (141 bp), using the ALB-S (5¢-GCTGTCATCTCTTGTGGGCTGT-3¢) and ALB-AS (5¢-AAACTCATGGGAGCTGCTGGTT-3¢) primers to determine the total cell number. The amplifications were performed in separate reactions using 240 ng DNA (equivalent to 39 000 cells), 1Â SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA) and 200 nM of each primer in an ABI Prism 7300 Sequence Detector System (Applied Biosystems), with the following cycle conditions: 2 min at 50 C and 10 min at 95 C followed by 45 cycles of 15 s at 95 C and 1 min at 65 C. Melting curves were performed after the end of the amplification cycles to validate the specificity of the amplified products. Standard curves were generated using 10-fold serial dilutions of DNA from MT2 cells (10 5 - 10 1 ), and normalized to three copies of the HTLV-1 pol gene and two copies of the cellular albumin gene per MT2 cell. All standard dilutions as well as control and individual samples were run in duplicate for both HTLV-1 and albumin DNA quantification. Standard curves were accepted when slopes were between À3.10 (efficiency of 110 %) and À3.74 (efficiency of 85 %) and the r 2 was >0.99. The value for the HTLV-1 PVL was reported as [(pol average copy number)/(albumin average copy number/2)]Â10 4 and expressed as the number of HTLV-1 copies 10 4 cells -1 .
Quantification of plasmatic chemokines
Chemokines were measured from plasma samples that were stored at À70 C. Plasma samples were centrifuged at 10000 g for 10 min and the supernatants were used for chemokine quantification. CCL2 (MCP-1 or monocyte chemoattractant protein-1), CCL5 (regulated on activation, normal T-cell expressed and secreted or RANTES) and IL8 (CXCL8) were quantified using the Human Chemokine CBA kit (Becton Dickinson, San Jose, CA, USA), according to the manufacturer's instructions. The fluorescence from the labelled beads was captured by a flow cytometer (Accuri C6, Becton Dickinson, BD, Franklin Lakes, NJ, USA), using 1800 events/sample, 300 beads/chemokine. The data were analysed using the FCAP Array Software Version 3.0 (Becton Dickinson, BD, San Jose, CA, USA).
Ancestry analysis
A total of 192 autosomal ancestry informative markers (AIM) developed for the Brazilian population [25] were genotyped on each individual to estimate an admixture and control its potential effect on the association between the frequency of Duffy polymorphisms (rs12075 and rs281477) and the phenotypes of interest. AIM genotyping was performed by OpenArray Real-Time PCR (Applied Biosystems). The evaluation of genomic ancestry was conducted using the Admixture program [26] . We used 200 bootstrap replicates (default) and k=3 (number of reference populations assumed for the analysis 
Statistical analysis
Statistical analysis was performed using the GraphPad Prism 5 software package (GraphPad Software, San Diego, CA, USA). The proportion analyses of gender and Duffy genotype frequency were performed by Fisher's exact test. Normal distribution of age, PVL and chemokine level were assessed using Kolgomorov-Smirnov's test. Since these variables were non-parametric, statistical differences between the groups were determined by Mann-Whitney's U-test.
The Hardy-Weinberg equilibrium (HWE) of Duffy polymorphisms was analysed using the exact test implemented in the web tool SNPstats [27] . Linear regression models were performed by the SNPstats tool to assess the proportion of variation in the HTLV-1 PVL level and chemokine concentrations explained by the Duffy polymorphisms, rs12075 and rs281477. A codominant genetic model was assumed for the rs12075 polymorphism (genotypes A/A vs A/G vs G/G), whereas an additive model was assumed for the rs281477 polymorphism (meaning that each allele copy modifies the risk in an additive form). When necessary, age, gender, and African, European or Native American ancestry were included as covariates in the analysis. The level of significance was considered to be P<0.05.
RESULTS
We analysed 162 AC, 135 HAM and 71 SN to investigate whether Duffy genotypes influence the level of HTLV-1 PVL and chemokines and are associated with HAM/TSP. As shown in Table 1 , the proportion of male and female, and age, were statistically different among the groups, with a higher frequency of female and older individuals in the infected groups. The Duffy genotypes showed a similar distribution among the groups, with a higher frequency of the wild FY*B allele (polymorphisms À46T and 125A). The infected groups do not fit the HWE (AC: P=0.006; HAM: P=0.026), with an excess of the homozygous at the locus rs281477 (GATA box-1). SN group, whereas IL8 was significantly lower in comparison to both infected groups (P<0.001).
The Duffy null phenotype was associated with a higher level of CCL2 in HTLV-1-infected individuals We evaluated whether Duffy polymorphisms influence the level of PVL in AC and HAM groups and the level of chemokines in infected and non-infected individuals. HAM patients showed significantly higher PVL than the AC group, independent of the Duffy genotype. Significant intragroup differences were not observed for polymorphisms rs12075 and rs2814778 (Table 2 and Fig. 1 ).
On the other hand, the level of CCL2 was associated with the GATA-1 box polymorphism, being significantly lower in AC, HAM and SN who did not express Duffy antigen on erythrocytes (Table 3 and Fig. 2 ). For the other chemokines, there were no plasma-level associations with Duffy genotypes in any of the three groups analysed (Table 3) .
Association of the Duffy null phenotype with the total WBC count and percentage of neutrophils Since it has been described that individuals with the Duffy null phenotype (À46CC) have significantly lower total WBC counts [20] and percentage of neutrophils [21] when compared to Duffy-positive (À46T) individuals, we analysed the level of these cells in the three groups according to Duffy genotypes (Table 4 and Fig. 3) . A significantly lower count of total WBC was associated with the absence of Duffy antigen on erythrocytes in the AC group and in all infected individuals (AC+HAM). In turn, individuals who did not express DARC on RBCs had a significantly decreased percentage of neutrophils when compared to subjects with Duffy-positive genotypes in all of the groups analysed (Table 4 and Fig. 3) .
Analysis of the association between the Duffy null phenotype, CCL2 and leukocytes, adjusted for ancestry Considering that polymorphisms in the Duffy gene are not homogenously distributed in world populations, we investigated the admixture profile of infected individuals to confirm whether the observed associations were true or spurious. This analysis could not be performed for all individuals due to samples being unavailable for testing. Using genetic markers informative for European, African and Amerindian ancestry, the individual ancestry estimated for these three populations was not different between the AC (n=123) and HAM (n=50) groups (Fig. 4) . Since the admixture difference among the groups was not significant, the analysis considering this parameter is not presented.
DISCUSSION
It is well described that HTLV-1 may trigger a neuroinflammatory disease, but the reason why only some infected carriers are susceptible to the pathogenic effects of the virus is still unknown. Host factors such as genetic polymorphisms are involved in the ability of a carrier to establish an efficient innate and adaptive immune response against HTLV-1. For example, it was previously described that the variability observed in human leukocyte antigens (HLA) are relevant to the risk of developing HAM/TSP [28, 29] . Considering that DARC on the surface of RBCs is a high affinity chemokine receptor that does not trigger activation signals, some studies suggest that DARC function as a sink to bind and internalize chemokines, clear them from sites of inflammation and systemic circulation, and prevent WBC activation [19, 30] . On the other hand, DARC expressed on endothelial cells has a role in enhancing leukocyte trafficking [18] . Thus, we hypothesized that Duffy gene polymorphisms that The data are median values of chemokines in pg ml À1 . The data were analysed using a linear regression-based test under an additive model of the allelic effect. The P-value indicates the significance of the association test between the level of each chemokine and Duffy polymorphism, adjusted for age and gender. The boldfaced text shows significant P values.
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Chemokine FY*A and FY*B genotype (rs12075) GATA-1 box genotype (rs2814778) alter their expression on the surface of RBCs may be associated with HTLV-1 infection outcome.
In the current study, we showed that the level of PVL was not associated with the Duffy antigen polymorphism (rs12075) nor with presence or absence of Duffy antigen on RBCs (rs281477) in HTLV-1-infected individuals, either asymptomatic or with neurologic disease. In addition, the frequency of Duffy genotypes was not significantly different among AC, HAM and the seronegative control group.
We also analysed whether the levels of chemokines were associated with DARC polymorphisms in HTLV-1 carriers and uninfected individuals. The levels of CCL2, IL8 and CCL5 chemokines were not influenced by the polymorphism rs12075 (125A>G Asp42Gly) in any of the groups analysed, whereas rs281477 (À46C) was associated with lower plasma level of CCL2 in infected (AC and HAM groups) and uninfected individuals. It is interesting to observe that in spite of Duffy genotypes, significant increases in the levels of IL8 and lower levels of CCL2 were seen in HTLV-1-infected groups, when compared to the seronegative group. The control group also showed higher levels of CCL5, but this difference was significant only in comparison to AC. Some studies have reported increased levels of CCL2 and CCL5 associated with HTLV-1 infection or with HAM/TSP [9, 31] . We have previously discussed that the divergent chemokine data observed among different studies in the context of HTLV-1 infection may be due to the heterogeneity of the individuals that had composed the analysed groups regarding age, gender, time of infection, duration of disease, PVL level and other possible confounding factors [32] . The present results may point to the inclusion of a Duffy null genotype among them.
Previous studies analysed the association of Duffy genotypes with chemokines, but not in the context of virus infection. Fig. 2 . Levels of CCL2 according to the Duffy polymorphisms, rs12075 and rs2814778. Significant intra-group differences were not seen among the three genotypes for the polymorphism rs12075. On the other hand, a higher level of CCL2 was associated with À46T (polymorphism rs2814778) that defines the presence of Duffy antigen on erythrocytes in all of the groups analysed. A linear regression-based test under an additive model of the allelic effect was used for statistical analysis. When a significant difference was shown by the linear regression test, we used the Kruskal-Wallis test followed by the Dunn multiple comparison test to compare each Duffy genotype with the others (TT vs TC; TT vs CC; TC vs CC) in the same group; * represents a significant difference (P<0.05). The line shows the median value.
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Schnabel and colleagues [33] showed an association between rs12075 and lower levels of CCL2, IL8 and CCL5 in serum from Caucasians, but not in plasma. They reported that approximately 20 % of variation in CCL2 serum concentration could be explained by rs12075, and they considered that the discrepancy between serum and plasma was due to the additional CCL2 that is liberated from Duffy antigen on erythrocyte by clotting. Voruganti and coworkers [34] also showed that rs12075 was associated with elevated levels of CCL2 in serum samples from Hispanic children, being responsible for approximately 10 % of the variability in CCL2 levels. They did not analyse plasma samples. Regrettably, these studies did not investigate the effect of GATA-1 polymorphism due to the rarity of À46C mutation in the ethnic groups analysed. Similar to our results, decreased plasma levels of CCL2 were previously described in individuals with the Duffy null genotype (À46 C/C) compared to persons who express DARC on the surface of RBCs [35, 36] . On the other hand, Lee and colleagues [37] showed that individuals homozygous for the Duffy null genotype had elevated levels of CCL2 and IL8 in plasma following lipopolysaccharide stimulation of whole blood, in comparison to heterozygote subjects. This observation is in agreement with the initial idea of the erythrocyte Duffy antigen acting as a sink for circulating chemokines [30] . However, other studies suggested that DARC delays the disappearance of chemokines from the plasma, thus maintaining plasma chemokine concentrations, since the absence of DARC in knockout mice was associated with lower levels of CCL2 and more rapid clearance of this chemokine from the plasma [38] . The role of chemokines as scavenging receptors is not attributed to DARC anymore. Instead, DARC may play a role in the transport of chemokines across barriers, allowing its concentration in tissues being difficult to reach [39] .
It is described that the Duffy null genotype is linked with a decrease of total WBC count and percentage of neutrophils, as shown by genome-wide association studies [20, 21] . We observed an association between the Duffy null genotype and a decreased percentage of neutrophils in all groups analysed. The association between the Duffy null genotype and a decreased total WBC count was also seen for the AC group, and probably was not significant in the HAM and SN groups because of the lower number of individuals analysed in these groups. It could be suggested that the association of lower plasma CCL2 levels with the À46 C/C genotype should be due to the decreased amount of WBC and neutrophils. However, there was no significant correlation between WBC count or percentage of neutrophils and CCL2 levels in any of the groups analysed (data not shown).
Because of the assumption that Duffy genotypes are associated with decreased counts of immune cells and can regulate the amount of circulating chemokines, different studies investigated the relationship between Duffy genotypes and HIV infection. In 2008, He and co-workers [40] originally described that HIV-1 binds to DARC on the surface of RBCs, enabling the virus to be transferred to target cells. They calculated that African Americans who did not express DARC on their RBCs are over 40 % more susceptible to acquiring HIV-1 infection. On the other hand, when HIV infection was already established, individuals possessing the Duffy null phenotype had a protective effect on HIV disease, including HIV-associated dementia. The association of the DARC À46 C/C genotype with susceptibility to acquire HIV and with survival advantage in HIV infection was also attributed to decreased neutrophils and WBC counts [41, 42] . After these studies were published, a number of other authors could not replicate these findings. Analysing HIV viral load, CD4+ T-cell count, rate of CD4+ T-cell decline, time to AIDS, time to death and other parameters, studies with different populations failed to find an association between the DARC genotype and progression to AIDS, or risk for HIV acquisition [43] [44] [45] [46] . These discrepancies could be attributed to the failure of the first studies to perform an appropriate control for population stratification, since DARC À46C has a large stratification effect due to being a marker for African ancestry, and thus they contributed to the creaton of spurious genetic associations.
Another work analysed the effect of the DARC polymorphism in the severity of HCV infection [47] . Studying three different cohorts of patients with HCV infection, the authors observed a significant association of serum CCL2 levels with fibrosis progression, but they did not detect the association between polymorphism rs12075 (125A>G, FY*B >FY*A) and HCV infection or liver fibrosis scores as being indicative of disease severity.
Although the effect of DARC on the circulating chemokines could suggest a role in the chronic virus pathologies, these previous studies showed that DARC is not directly associated with the acquisition or disease severity in HIV or HCV infection. Our results provide evidence that HTLV-1 should be included on this list. In addition, our results draw attention to the fact that Duffy genotypes may be a confounding factor in studies to define inflammatory biomarkers in HTLV-1-infected populations with diverse ancestrally, since Duffy polymorphisms present different frequencies among worldwide populations.
In summary, we showed, for the first time, that the frequency of the Duffy null genotype was not significantly different among AC, HAM and SN, and that PVL level was not associated with DARC polymorphisms. Thus, our results support the absence of the effect of Duffy genotypes on the occurrence of HTLV infection or HAM/TSP. Decreased CCL2 levels were associated with the À46C polymorphism, but although DARC influences circulating concentrations of chemokines, it does not seem to be a genetic factor that characterizes risk for HAM/TSP. It is important to emphasize that we ensured an appropriate control for population stratification and we believe that our cohort is powered to detect the true effects of the DARC genotype, since we observed the association between À46 C/C with low WBC and neutrophils count, as expected. 
